http://www.advfn.com/nyse/rss.asp?symbol=VRX Valeant Pharma Company Newsfeed en Wed, 15 May 2013 19:00:14 EDT Wed, 15 May 2013 19:00:14 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=57595213&headline=novartis-considers-possible-bid-for-actavis http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=57595213&headline=novartis-considers-possible-bid-for-actavis <div class='newsbody'><p> A heated takeover battle has erupted around generic-drug company Actavis Inc. (ACT) as industry players seek to shore themselves up amid increasing competition and fewer new knock-off-drug opportunities. </p> <p> Valeant Pharmaceuticals International Inc. (VRX, VRX.T) and Mylan... Wed, 15 May 2013 19:00:14 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=57521897&headline=actavis-in-early-talks-about-buyout-of-warner-chilcott http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=57521897&headline=actavis-in-early-talks-about-buyout-of-warner-chilcott <div class='newsbody'><p> Actavis Inc. (ACT), a big maker of generic drugs that was an acquisition target a month ago, is in early talks about a potential acquisition of Irish drug maker Warner Chilcott PLC (WCRX), a person familiar with the matter said. </p> <p> The talks come weeks after Valeant Pharmaceuticals... Fri, 10 May 2013 15:10:20 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=57356106&headline=u-s-hot-stock-futures-hot-stocks-to-watch http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=57356106&headline=u-s-hot-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies with shares expected to actively trade in Monday's session is Actavis Inc. (ACT). </p> <p> Drug maker Valeant Pharmaceuticals International Inc. (VRX, VRX.T) is in talks to acquire rival Actavis for more than $13 billion, The Wall Street Journal reported... Mon, 29 Apr 2013 07:01:48 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=57064616&headline=merz-pharma-withdraws-offer-for-obagi-medical-after-valeants http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=57064616&headline=merz-pharma-withdraws-offer-for-obagi-medical-after-valeants <div class='newsbody'><pre> By Tess Stynes </pre> <p> Merz Pharma Group withdrew its roughly $385 million offer to acquire Obagi Medical Products Inc. (OMPI), citing Valeant Pharmaceuticals International Inc.'s (VRX, VRX.T) sweetened bid for the specialty pharmaceutical company last week. </p> <p> "Obagi... Mon, 08 Apr 2013 08:22:08 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=57027803&headline=valeant-to-launch-own-version-of-generic-zovirax-in-response http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=57027803&headline=valeant-to-launch-own-version-of-generic-zovirax-in-response <div class='newsbody'><pre> By Saabira Chaudhuri </pre> <p> Valeant Pharmaceuticals International Inc. (VRX, VRX.T) said it will launch a generic version of its Zovirax ointment Thursday after Mylan Inc. (MYL) received approval to launch a similar product, a move that is expected to cut the specialty-pharmaceutical... Thu, 04 Apr 2013 09:00:14 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=57009311&headline=valeant-boosts-price-for-obagi-to-420-million-besting-merz http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=57009311&headline=valeant-boosts-price-for-obagi-to-420-million-besting-merz <div class='newsbody'><pre> By Ben Fox Rubin </pre> <p> Valeant Pharmaceuticals International Inc. (VRX, VRX.T) agreed to raise its offer for Obagi Medical Products Inc. (OMPI) by 22%, besting Merz Pharma Group's recently disclosed bid for the specialty pharmaceutical company. </p> <p> Valeant now will... Wed, 03 Apr 2013 09:02:50 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=56989553&headline=merz-pharma-offers-to-buy-obagi-looks-to-top-valeant-deal http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=56989553&headline=merz-pharma-offers-to-buy-obagi-looks-to-top-valeant-deal <div class='newsbody'><pre> By Ben Fox Rubin </pre> <p> Merz Pharma Group has offered to buy specialty pharmaceutical company Obagi Medical Products Inc. (OMPI) for about $385 million, looking to top a $345 million bid from Valeant Pharmaceuticals International Inc. (VRX, VRX.T) a few weeks ago. </p> <p>... Tue, 02 Apr 2013 08:44:11 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=56830723&headline=valeant-pharmaceuticals-agrees-to-acquire-obagi-medical-for-360 http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=56830723&headline=valeant-pharmaceuticals-agrees-to-acquire-obagi-medical-for-360 <div class='newsbody'><pre> By Tess Stynes </pre> <p> Valeant Pharmaceuticals International Inc. (VRX, VRX.T) agreed to acquire Obagi Medical Products Inc. (OMPI) for about $360 million, a deal expected to supplement Valeant's presence in the dermatology and plastic-surgery sectors. </p> <p> Under the... Wed, 20 Mar 2013 10:59:27 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=56070337&headline=endo-health-in-talks-with-potential-buyers-reuters http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=56070337&headline=endo-health-in-talks-with-potential-buyers-reuters <div class='newsbody'><p> Endo Health Solutions Inc. (ENDP) is in talks with drug makers about selling itself, Reuters reported, citing people familiar with the matter. </p> <p> Shares were recently 9% higher at $31.23 after tripping a single-stock circuit breaker. The stock is down 13% over the last... Wed, 30 Jan 2013 15:48:22 EST http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=56041852&headline=anacor-plunges-as-investors-compare-nail-fungus-drug-with-peers http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=56041852&headline=anacor-plunges-as-investors-compare-nail-fungus-drug-with-peers <div class='newsbody'><pre> By Saabira Chaudhuri </pre> <p> Anacor Pharmaceuticals Inc.'s (ANAC) shares tumbled early Tuesday despite what the biopharmaceutical company characterized as positive preliminary late-stage results for a study of its nail-fungus infection drug. </p> <p> Shares--which surged... Tue, 29 Jan 2013 09:05:39 EST http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=55437279&headline=valeants-medicis-unit-sues-anacor-alleging-violation-of-research http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=55437279&headline=valeants-medicis-unit-sues-anacor-alleging-violation-of-research <div class='newsbody'><p> Medicis Pharmaceutical Corp., which was purchased by Valeant Pharmaceuticals International Inc. (VRX) on Tuesday, sued Anacor Pharmaceuticals Inc. (ANAC), alleging violation of a research agreement, Bloomberg News reported Wednesday. </p> <p> Medicis said in court papers filed... Wed, 12 Dec 2012 18:31:25 EST http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=55333111&headline=garmin-to-join-s-p-500-index-replacing-rr-donnelley http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=55333111&headline=garmin-to-join-s-p-500-index-replacing-rr-donnelley <div class='newsbody'><pre> By Nathalie Tadena </pre> <p> Standard &amp; Poor's said it will add personal-navigation devices maker Garmin Ltd. (GRMN) to its S&amp;P 500 index, replacing printing company R.R. Donnelley &amp; Sons Co. (RRD). </p> <p> Garmin shares rose 3.3% to $41 after hours. The shares... Wed, 05 Dec 2012 18:13:24 EST http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=54952809&headline=medicis-pharma-shares-fall-on-q-med-lawsuit http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=54952809&headline=medicis-pharma-shares-fall-on-q-med-lawsuit <div class='newsbody'><pre> By Anna Prior </pre> <p> Q-Med Inc., a division of pharmaceutical company Galderma, has sued Medicis Pharmaceutical Corp. (MRX) over the contracts for several dermal filler products in connection with Medicis's planned merger with Valeant Pharmaceuticals International Inc... Fri, 09 Nov 2012 15:18:28 EST http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=54940016&headline=meda-3q-hit-by-currency-effects-lower-collaboration-revenue http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=54940016&headline=meda-3q-hit-by-currency-effects-lower-collaboration-revenue <div class='newsbody'><pre> By Dominic Chopping </pre> <p> STOCKHOLM--Swedish pharmaceutical company Meda AB (MEDA-A.SK) said Friday that third quarter sales were affected by significant negative currency effects and planned lower revenues from the collaboration agreement with Valeant (VRX), as it posted... Fri, 09 Nov 2012 05:18:07 EST http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=54166416&headline=valeant-president-specialty-pharmaceuticals-coo-de-silva-to http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=54166416&headline=valeant-president-specialty-pharmaceuticals-coo-de-silva-to <div class='newsbody'><pre> By Nathalie Tadena </pre> <p> Valeant Pharmaceuticals International Inc. (VRX) said its president, Rajiv De Silva, will be leaving the company after the close of its acquisition of Medicis Pharmaceutical Corp. (MRX) to pursue other interests. </p> <p> Mr. De Silva, who also... Thu, 13 Sep 2012 18:22:09 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=52802875&headline=applications-given-early-antitrust-clearance http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=52802875&headline=applications-given-early-antitrust-clearance <div class='newsbody'><p> The Hart-Scott-Rodino Act requires under certain circumstances that prospective acquirers of voting securities or assets apply for clearance from regulators. Requests for early termination or clearance are granted when the Federal Trade Commission and the antitrust division... Mon, 18 Jun 2012 11:49:46 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=52162567&headline=tip-sheet-janus-fund-tries-to-manage-risk-of-drug-stocks http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=52162567&headline=tip-sheet-janus-fund-tries-to-manage-risk-of-drug-stocks <div class='newsbody'><p> (This article was originally published Wednesday.) </p> <pre> </pre> <p> --Janus Global Life Sciences fund has year-to-date return of 14.62% </p> <p> --Manager tries to limit exposure to volatility among small-cap drug stocks </p> <p> --Pharmasset, Regeneron surges have helped... Thu, 26 Apr 2012 08:04:53 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=51776347&headline=bausch-lomb-to-acquire-ista-in-cash-deal http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=51776347&headline=bausch-lomb-to-acquire-ista-in-cash-deal <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Bausch + Lomb Monday agreed to acquire ISTA Pharmaceuticals Inc. (ISTA), swooping in with a higher offer for the eye-care company deal less than two months after a rival suitor withdrew its bid. </p> <p> ISTA shares jumped 7.8% to $9.03 after hours... Mon, 26 Mar 2012 20:51:27 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=51769533&headline=valeant-to-buy-russian-specialty-pharma-company-for-180-million http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=51769533&headline=valeant-to-buy-russian-specialty-pharma-company-for-180-million <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Valeant Pharmaceuticals International Inc.'s (VRX) buying spree continued Monday with the planned $180 million purchase of Natur Produkt International JSC, a Russian company which markets over-the-counter pharmaceuticals such as cough and cold remedies... Mon, 26 Mar 2012 10:14:47 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=51598121&headline=valeant-to-buy-branded-generics-assets-from-gerot-lannach http://www.advfn.com/nyse/StockNews.asp?stocknews=VRX&article=51598121&headline=valeant-to-buy-branded-generics-assets-from-gerot-lannach <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Valeant Pharmaceuticals International Inc. (VRX) said Tuesday it's acquiring from Austria's Gerot Lannach certain branded generics assets that generate the bulk of their sales in Russia. </p> <p> Mississauga, Ont.-based Valeant said the assets generated... Tue, 13 Mar 2012 09:34:51 EDT